Stockreport

Valneva inks licensing deal with Elaris for vaccine technology [Seeking Alpha]

Valneva SE - American Depositary Shares  (VALN) 
PDF to the technology behind a vaccine candidate for Clostridioides difficile, a bacterium causing diarrhea. The company, founded by two former employees of Valneva ( Fr [Read more]